Potential drug therapy problems: identification and associated factors among Primary Health Care users
DOI:
https://doi.org/10.33448/rsd-v10i9.17417Keywords:
Pharmaceutical services; Comprehensive medication management; Systemic arterial hypertension; Diabetes mellitus; Myocardial infarction; Cardiovascular diseases.Abstract
Cardiovascular diseases (CVD) and diabetes mellitus (DM) are chronic non-communicable diseases with high prevalence. Several factors contribute to its lack of control, especially those related to pharmacotherapy, often leading to problems related to the use of medication (DTP). Objective: To identify potential DTPs for the treatment of CVD and DM, as well as associated factors, using big data from users of the Unified Health System (SUS) in a municipality. Methods: A cross-sectional study was carried out based on big data of patients for whom at least one medication was dispensed in SUS pharmacies in the primary healthcare network in April 2019 (n = 4,800). Potential DTPs involving the treatment of CVD or DM were identified based on data on medications dispensed, demographic and clinical characteristics. To classify these potential PRMs, the Pharmacotherapy Workup method was used. Logistic regression analyzes were performed to identify factors associated with identifying at least one potential MRP. Results: The results showed that 25% of the population had at least one potential DTP, with a total of 1,914 potential PRMs being identified. In the multivariate model, age group was statistically associated with the identification of at least one potential DTP. Conclusions: This study allows tracing the frequency of important potential DTPs and associated factors, pointing out some priorities that must be addressed by the public primary health care system, supporting the planning of the implementation of drug therapy management services aimed at the studied population.
References
American Diabetes Association (2015). Diagnosis and Classification of Diabetes. Diabetes Care. 38(1), S8-S16.
American Geriatrics Society (2019). Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am GeriatrSoc; 67, 674-94.
Arnett, D. K., Co-Chair, R. S. B., Co-Chair, M. A. A., Andrew, B. B., Zachary, D. G., Ellen, J. H., Cheryl, D. H., Amit, K., Donald, L. J., William, M., Erin, D. M., Michael, D. M., Daniel, M., Sidney, C. S., Salim, S. V., Kim, A. W., Joseph, Y. & Boback, Z. (2019). ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. <http://ahajournals.org>.
ATLAS IDF (2019). <https://diabetesatlas.org/en/resources/.>
Bahia, L. R., Araujo, D. V., Schaan, B. D., Dib, S. A., Negrato, C. A., Leão, M. P. S., Ramos, A. J. S., Forti, A. C., Gomes, M. B., Foss, M. C., Monteiro, R. A., Sartorelli, D. & Franco, L. J. (2011). The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health. 14, S137-40.
Borges, A. P. S., Guidoni, C. M., Ferreira, L. D., Freitas, O. & Pereira, L. R. L. (2010). The Pharmaceutical care of patients with type 2 diabetes mellitus. Pharm World Sci. v.32 n.6 p.730-6.
Bowan, L., Mafham, M. & W., Karl (2018). Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. The ASCEND Study Collaborative Group*. The New England Journal of Medicine. 379, 1529-39.
BRASIL. (2010). Ministério da Saúde. Hipertensão arterial sistêmica – HAS e Diabetes mellitus – DM PROTOCOLO. Cadernos de Atenção Básica. Brasília: Ministério da Saúde.
Gaziano, J. M., Brotons, C., Coppolecchia, R., Cricelli, C., Daruis, H., Gorelick, P. B., Howard, G., Pearson, T., Rothwell, P. M., Ruilope, L. M., Tendera, M. & Gianni Tognoni (2018). Aspirin to Reduce Risk of Initial Vascular Events – ARRIVE. 392, 988-990.
Cid, Annaline (2008). Avaliação da Efetividade da Atenção Farmacêutica no Controle da Hipertensão Arterial. Dissertação de mestrado. Universidade Federal de Ouro Preto, Minas Gerais, Brasil.
Cipolle, R. J., Strand, L. M., & Morley, P. C. (2012). Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services. McGraw-Hill Medical Publishing; Ed.3
Coelho, A., Vilares, C., Silva, M., Rodrigues, C., Costa, M., Gordicho, S. & Caetano, P. (2017). Investigação sobre adesão à terapêutica na população portuguesa: uma revisão de âmbito. Revista Portuguesa de Medicina Geral e Familiar, 33. 262-276.
Coleman, C., Limone, B., Sobieraj, D. M., Lee, S., Roberts, M. S., Kaur, R. & Tawfikul, A. (2012). Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm. 18(7): 527-39.
Dib, M., Riera, R., Ferraz, M. (2010). Estimated annual cost of arterial hypertension treatment in Brazil. Rev Panam Salud Pública/Pan Am J Public Health. 27, 125-31.
Filha, M. M. T., Junior, P. R. B. S., Damacena, G. N, Szwarcwald, C. L. (2015). Prevalência de doenças crônicas não transmissíveis e associação com autoavaliação de saúde: Pesquisa Nacional de Saúde, 2013. RevBrasEpidemiol; 18, 83-96.
Instituto Brasileiro de Geografia e Estatística. (2018). <https://cidades.ibge.gov.br/brasil/mg/congonhas/panorama>.
Lessa, I. (2006). Impacto social da não adesão ao tratamento da hipertensão arterial. Rev Bras Hipertens. 2006; 13(1): 39-46.
LV, X., Zhang, Y., Niu, Y., Song, Q. & Zhao, Q. (2018). Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus: A PRISMA-compliant systematic review and meta-analysis. Medicine. 97(15): e0256.
Mcneil, J., Nelson, M., Woods, R. L., Lockery, J. L., Wolfe, R., Reid, C. M., Kirpach, B., Shah, R. C., Ives, D. G., Storey, E., Ryan, J., Tonkin, A. M., Newman, A. B., Williamson, J. D., Margolis, K. L., Ernst, M. E., Abhayaratna, W. P., Stocks, N., Fitzgerald, S. M., Orchard, S. G., Trevaks, R. E., Beilin, L. J., Donnan, G. A., Gibbs, P., Johnston , C. I., Radziszewska, B., Grimm, R. & Murray, A. M. (2018). For the ASPREE Investigator Group. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. The New England Journal of Medicine. 379, 1519-28.
Mendonça, S., Melo, A. C., Pereria, G. C. C., Santos, D. M. S. S., Grossi, E. B., Sousa, M. C. B. V., Ramalho de Oliveira, D. & Soares, A. C. (2016). Clinical outcomes of medication therapy management services in primary health care. Braz. J. Pharm. Sci. 52, 365–373.
Mishima, E., Hanura, Y. & Arima, H. (2019). Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials. Hypertens Res. 42(4): 469-482.
Neves, C. M., Nascimento, M. M. G., SILVA, D. A. M. & Ramalho de Oliveira, D. (2019). Clinical Results of Comprehensive Medication Management Services in Primary Care in Belo Horizonte. Pharmacy, 7(58).
Obreli-neto, P. R., Marusic, S., Guidoni, C. M., Baldoni, A. O., Renovato, R. D., Pilger, D., Cuman, R. K. N. & Pereira, L. R. L. (2015).Economic Evaluation of a Pharmaceutical Care Program for Elderly Diabetic and Hypertensive Patients in Primary Health Care: A 36-Month Randomized Controlled Clinical Trial. Journal of Managed Care & Specialty Pharmacy JMCP. 21(1).
Oliveira, G. M. M., Brant, L. C. C., Polanczyk, C. A., Biolo, A., Nascimento, B. R., Malta, D. C., Souza, M. F. M., Soares, G. P., Junior, G. F. X., Machline-Carrion, J., Bittencourt, M. S., Pontes-Neto, O. M., Silvestre, O. M., Teixeira, R. A., Sampaio, R. O., Gaziano, T. A., Roth, G. A. & Ribeiro, A. L. P. (2020). Cardiovascular Statistics – Brazil 2020. Arq. Bras. Cardiol., 115, 308-439.
Osterberg, L. & Blaschke, T. (2005). Adherence to medication. N Engl J Med. 353(5):487-97.
Ramalho de Oliveira, D. (2011). Atenção Farmacêutica: da filosofia ao gerenciamento da terapia medicamentosa. RCN, 29 p.
Ramalho de Oliveira, D., Brummel, A. & Miller, D. (2010). Medication therapy management: 10 years of experience in a large integrated health care system. Journal of Managed Care Pharmacy, 16, 185-195.
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., Bonny, A., Brauer, M., Brodmann, M., Cahill, T. J., Carapetis, J., Catapano, A. L., Chugh, S. S., Cooper, L. T., Coresh, J., Criqui, M., DeCleene, M., Eagle, K. A., Emmons-Bell, S. Feigin, V., Fernández-Solà, J., Fowkes, G., Gakidou, E., Grunsy, S. M., He, F. J., Howard, G., Hu, F., Inker, L., Karthikeyan, G., Kassebaum, N., Koroshetz, W., Lavie, C., Lloyd-Jones, D., Lu, H. S., Mirijello, A., Temesgen, A. M., Mokdad, L., Moran, A. E., Muntner, P., Narula, J., Neal, B., Ntsekhe, M., Oliveira, G. M., Otto, C., Owolabi, M., Pratt, M., Rajagopalan, S., Reitsma, M., Ribeiro, A. L. P., Rigotti, N., Rodgers, A., Sable, C., Shakil, S., Sliwa-Hahnle, K., Stark, B., Sundström, J., Timpel, P., Tleyeh, I. M., Valgimigli, M., Vos, T., Whelton, P. K., Yacoub, M., Zuhlke, L., Murray, C. & Fuster, V. (2020). Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec, 76 (25) 2982–3021.
Santos, F. T. C., Silva, D. L. M. & Tavares, N. U. L. (2018). Pharmaceutical clinical services in basic care in a region of the municipality of São Paulo. Braz j pharmsci. 54, 1-11.
Santos, T. O., Nascimento, M. M. G., Ramalho de Oliveira, D., Nascimento, Y. A., Oliveira, C. B., Martins, U. C. M. & Silva, D. F. (2019). Interações medicamentosas entre idosos acompanhados em serviço de gerenciamento da terapia medicamentosa da Atenção Primária. Einstein (São Paulo), 17.
Silva, C. S. S. L., Koopmans, F. F., Daher, D. V. (2016). O Diagnóstico Situacional como ferramenta para o planejamento de ações na Atenção Primária a Saúde. Revista Pró-UniverSUS. 7. 30-33.
ª Diretriz Brasileira de Hipertensão Arterial (2016). Sociedade Brasileira de Cardiologia.107, 3.
Souza, I. G., Oliveira, G. C., Brum, G. A., Neves, C. M., Nascimento, M. M. G., SILVA, D. A. M. & Ramalho de Oliveira, D. (2017). Resultados Clínicos do Serviço de Gerenciamento da Terapia medicamentosa em um Ambulatório de Diabetes. Rev. Bras. Farm. Hosp. Serv. Saúde 8(3): 19-24.
Stevens, B., Pezzullo, L., Verdian, L., Tomlinson, J., George, A. & Bacal, F. (2018). Os Custos das Doenças Cardíacas no Brasil. Arq Bras Cardiol. 111, 29-36.
V Diretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto Agudo do Miocárdio com Supradesnível do Segmento ST (2015). ArqBrasCardiol. 105(2):1-105.
Whelton, P., Carey, R. M., Aronow, W. S., Casey Jr, D. E., Collins, K. J., Himmelfarb, C. D., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W.,M., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith Jr, S. C., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Williamson, J. D. & Wright Jr , J. D. (2017). ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Prac-tice Guidelines. J Am CollCardiol.
Yang, Y; West-Strum, D. (2013). Compreendendo a farmacoepidemiologia. AMGH. 198 p.
Zermansky, A. G., Petty, D. R., Raynor, D. K., Freemantle, N., Vail, A. & Lowe, C. J. (2001). Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. Brit. Med. J. 323, 1-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Flávia Cristina Moura Gualberto; Aline Angélica de Souza Valentin; Djenane Ramalho de Oliveira; Mariana Martins Gonzaga do Nascimento; Edna Afonso Reis
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
